CD8A and cancer: We co-cultured tumor associated antigen (TAAs: SSX2, PRAME, MAGEA4, SURVIVIN, and NY-ESO-1) specific CD8+ T cells with partially HLA-matched cancer cells expressing SURVIVIN, MAGE-A3, and MAGE-A4 (Figure S4).